GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
SEQUX
Price
$189.01
Change
-$4.72 (-2.44%)
Updated
Apr 3 closing price
Net Assets
3.49B
Ad is loading...

GFACX vs SEQUX

Header iconGFACX vs SEQUX Comparison
Open Charts GFACX vs SEQUXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
Sequoia
Price$189.01
Change-$4.72 (-2.44%)
VolumeN/A
Net Assets3.49B
GFACX vs SEQUX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. SEQUX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and SEQUX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. SEQUX (3.49B). SEQUX pays higher dividends than GFACX: SEQUX (0.33) vs GFACX (0.00). GFACX was incepted earlier than SEQUX: GFACX (24 years) vs SEQUX (55 years). GFACX (1.36) is less costly to investors than SEQUX (1.11). GFACX is a more actively managed with annual turnover of: 25.00 vs. SEQUX (9.00). GFACX has a lower initial minimum investment than SEQUX: GFACX (250) vs SEQUX (5000). SEQUX annual gain was more profitable for investors over the last year : 11.51 vs. GFACX (-1.75). SEQUX return over 5 years is better than : 73.33 vs. GFACX (59.73).
GFACXSEQUXGFACX / SEQUX
Total Expense Ratio1.361.00136%
Annual Report Gross Expense Ratio1.361.11123%
Fund Existence24 years55 years-
Gain YTD-5.0035.569-90%
Front LoadN/AN/A-
Min. Initial Investment25050005%
Min. Initial Investment IRAN/AN/A-
Net Assets280B3.49B8,023%
Annual Yield % from dividends0.000.33-
Returns for 1 year-1.7511.51-15%
Returns for 3 years0.6318.583%
Returns for 5 years59.7373.3381%
Returns for 10 years44.46-20.62-216%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences